Lung cancer risk to personalise annual and biennial follow-up computed tomography screening

Thorax

Volumn 73, Issue 7, 2018, Pages 626-633

  Schreuder, Anton ^a   Schaefer Prokop, Cornelia M ^a,b   Scholten, Ernst T ^a   Jacobs, Colin ^a   Prokop, Mathias ^a   Van Ginneken, Bram ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c FRAUNHOFER MEVIS   (Germany)

Author keywords

Clinical Epidemiology; Lung Cancer

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BOOTSTRAPPING; CANCER MORPHOLOGY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SAFETY; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 85050976448     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211107     Document Type: Article

References (39)

1. A berle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409
2. Baldwin DR, Duffy SW, Devaraj A, et al. Optimum low dose CT screening interval for lung cancer: the answer from NELSON?. Thorax 2017;72:6-7
3. E rrico A. Lung cancer: Heterogeneity in space and time. Nat Rev Clin Oncol 2014;11:684
4. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311-20
5. T ammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36
6. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9
7. Patz EF, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590-9
8. Mangiafico SS. An R companion for the handbook of biological statistics, version 1.3.0. New Brunswick: Rutgers Cooperative Extension, 2015:242-55. http://rcompanion. org/documents/RCom pani onBi oSta tistics.pdf (accessed 28 Apr 2017)
9. Bodarenko V. FI Consulting. The bootstrap approach to managing model uncertainty. 2015 https://rstudio-pubs-static. s3. Amazonaws. com/90467-c702 06f3 dc86 4d53 bf36.0722 07ee011d. html# area-under-The-roc-curve
10. E fron B, Tibshirani R. An introduction to the bootstrap. United States of America: Chapman and Hall, 1993
11. N ewcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72
12. Hosmer DW, Lemesbow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory Methods 1980;9:1043-69
13. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-74
14. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8
15. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26
16. C assidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6
17. E tzel CJ, Kachroo S, Liu M, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res 2008;1:255-65
18. T ammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103:1058-68
19. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-54
20. Wilson DO, Weissfeld. A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. Lung Cancer 2015;89:31-7
21. Winkler Wille MM, van Riel SJ, Saghir Z, et al. Predictive accuracy of the PanCan lung cancer risk prediction model -external validation based on CT from the Danish Lung Cancer Screening Trial. Eur Radiol 2015;25:3093-9
22. Zhao H, Marshall HM, Yang IA, et al. Screen-detected subsolid pulmonary nodules: long-Term follow-up and application of the PanCan lung cancer risk prediction model. Br J Radiol 2016;89:20160016
23. van Riel SJ, Ciompi F, Jacobs C, et al. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines. Eur Radiol 2017;27:4019-29
24. Marshall HM, Zhao H, Bowman RV, et al. The effect of different radiological models on diagnostic accuracy and lung cancer screening performance. Thorax 2017;72:1147-50
25. White CS, Dharaiya E, Campbell E, et al. The vancouver lung cancer risk prediction model: Assessment by using a subset of the national lung screening trial cohort. Radiology 2017;283:264-72
26. C assidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007;120:1-6
27. McCarthy WJ, Meza R, Jeon J, et al. Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models. Risk Anal 2012;32(Suppl 1):S69-84
28. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res 2008;1:250-4
29. Young RP, Hopkins RJ, Hay BA, et al. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 2009;85:515-24
30. L i H, Yang L, Zhao X, et al. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model. BMC Med Genet 2012;13:118
31. Hippisley-Cox J, Coupland C. Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2011;61:715-23
32. Park S, Nam BH, Yang HR, et al. Individualized risk prediction model for lung cancer in Korean men. PLoS One 2013;8:e54823
33. I yen-Omofoman B, Tata LJ, Baldwin DR, et al. Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier. Thorax 2013;68:451-9
34. Maisonneuve P, Bagnardi V, Bellomi M, et al. Lung cancer risk prediction to select smokers for screening CT-A model based on the Italian COSMOS trial. Cancer Prev Res 2011;4:1778-89
35. Sverzellati N, Silva M, Calareso G, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol 2016;26:3821-9
36. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41
37. Pinsky PF, Gierada DS, Nath PH, et al. National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology 2013;268:865-73
38. Field JK, Marcus MW, Oudkerk M. Risk assessment in relation to the detection of small pulmonary nodules. Transl Lung Cancer Res 2017;6:35-41
39. Heitzman ER, Markarian B, Raasch BN, et al. Pathways of tumor spread through the lung: radiologic correlations with anatomy and pathology. Radiology 1982;144:3-14.